Homeobox Protein CDX2 as a Prognostic Biomarker in Solid Malignancies: A Meta-Analysis

Oncotarget - United States
doi 10.18632/oncotarget.20808
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

LncRNA as a Diagnostic and Prognostic Biomarker in Bladder Cancer: A Systematic Review and Meta-Analysis

OncoTargets and Therapy
OncologyPharmacology
2018English

Prognostic Role of MicroRNA-181a/b in Hematological Malignancies: A Meta-Analysis

PLoS ONE
Multidisciplinary
2013English

The Prognostic Value of CSCs Biomarker CD133 in NSCLC: A Meta-Analysis

Oncotarget
Oncology
2016English

Prognostic Significance of microRNA-101 in Solid Tumor: A Meta-Analysis

PLoS ONE
Multidisciplinary
2017English

Prognostic Value of Bone Scan Index as an Imaging Biomarker in Metastatic Prostate Cancer: A Meta-Analysis

Oncotarget
Oncology
2017English

Circular RNA as a Biomarker for Cancer: A Systematic Meta‑analysis

Oncology Letters
Cancer ResearchOncology
2018English

Prognostic Significance of 8-Hydroxy-2′-Deoxyguanosine in Solid Tumors: A Meta-Analysis

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Prognostic Value of FOXQ1 in Patients With Malignant Solid Tumors: A Meta-Analysis

OncoTargets and Therapy
OncologyPharmacology
2017English

Prognostic Value of Aspartate Aminotransferase to Platelet Ratio Index as a Noninvasive Biomarker in Patients With Hepatocellular Carcinoma: A Meta-Analysis

Cancer Management and Research
Oncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy